The Fund aims to achieve long-term capital growth through investment in North American securities using a value based investment philosophy.
Name | % Net Assets |
---|---|
Lincoln National | 2.7% |
Merck & Co | 2.7% |
Nucor | 2.7% |
JP Morgan | 2.7% |
Hartford Financial | 2.6% |
Morgan Stanley | 2.6% |
Wells Fargo | 2.6% |
Cigna | 2.6% |
Apache | 2.6% |
Pfizer | 2.5% |
Key | % Net Assets |
---|---|
Lincoln National | 2.7% |
Merck & Co | 2.7% |
Nucor | 2.7% |
JP Morgan | 2.7% |
Other | 89.2% |
Date | 09-Nov-2018 |
---|---|
NAV | 17.01p |
Currency | GBP |
Change | 0.16p |
% | 0.94% |
YTD change | 17.01p |
YTD % | n/a |
Fund Inception | 01/07/2005 |
---|---|
Fund Manager | Richard Brody |
TER | 1.69 (28-Feb-2014) |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 4.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research